Shares of biotechnology company CollaGenex Pharmaceuticals Inc. dropped Monday after an analyst downgraded the company, saying the Phase II trial results for its acne treatment incyclinide were disappointing.
From: biz.yahoo.com
CollaGenex Shares Drop on Downgrade
Posted by Ruslan Abuzant at 4:31 PM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment